EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Placental glycosylation senses the anti-angiogenic milieu induced by human sFLT1 during pregnancy

Kürsat Kirkgöz, Rebekka Vogtmann, Yiran Xie, Fangqi Zhao, Alina Riedel, Lisa-Marie Adam, Nancy Freitag, Charlotte Harms, Mariana G Garcia, Torsten Plösch, Alexandra Gellhaus, Sandra M Blois

Journal of Reproductive Immunology · 2024-08 · 164 · 104284

DOI: 10.1016/j.jri.2024.104284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024-08. Verfasst von Kürsat Kirkgöz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Fetal Medicine, Glycoimmunology Research Group, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-1, Pre-Eclampsia, Placenta. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research Bonn Office, Deutsche Forschungsgemeinschaft, Universitätsklinikum Hamburg-Eppendorf.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal placental angiogenesis during gestation resulting from high levels of anti-angiogenic factors, soluble fms-like tyrosine kinase-1 (sFLT1) and soluble endoglin, has been implicated in the progression of preeclampsia (PE). This heterogeneous syndrome (defined by hypertension with or without proteinuria after 20 weeks of pregnancy) remains a major global health burden with long-term consequences for both mothers and child. Previously, we showed that in vivo systemic human (hsFLT1) overexpression led to reduced placental efficiency and PE-like syndrome in mice. Galectins (gal-1, -3 and -9) are critical determinants of vascular adaptation to pregnancy and dysregulation of the galectin-glycan circuits is associated with the development of this life-threatening disease. In this study, we assessed the galectin-glycan networks at the maternal-fetal interface associated with the hsFLT1-induced PE in mice. We observed an increase on the maternal gal-1 expression in the decidua and junctional zone layers of the placenta derived from hs FLT1high pregnancies. In contrast, placental gal-3 and gal-9 expression were not sensitive to the hsFLT1 overexpression. In addition, O- and N-linked glycan expression, poly-LacNAc sequences and terminal sialylation were down-regulated in hsFLT1 high placentas. Thus, the gal-1-glycan axis appear to play an important role counteracting the anti-angiogenic status caused by sFLT1, becoming critical for vascular adaptation at the maternal-fetal interface.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-1Pre-EclampsiaPlacentaPregnancyFemaleAnimalsHumansMiceGlycosylationGalectinsNeovascularization, PathologicDisease Models, Animal

Stichwörter der Autor:innen

GalectinsMaternal-fetal pathophysiologyPlacental glycocodePreeclampsiasFLT1

Substanzen

Vascular Endothelial Growth Factor Receptor-1FLT1 protein, humanGalectins

Autor:innen und Institutionen

  • Department of Obstetrics and Fetal Medicine, Glycoimmunology Research Group, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Gynecology and Obstetrics, University Hospital Essen, Germany.
  • Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Perinatal Neurobiology, Department of Human Medicine, School of Medicine and Health Sci…
  • Department of Obstetrics and Fetal Medicine, Glycoimmunology Research Group, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: s.blois@uke.de.

Förderung

  • Federal Ministry of Education and Research Bonn Office
  • Deutsche Forschungsgemeinschaft
  • Universitätsklinikum Hamburg-Eppendorf
  • Else Kroner-Fresenius Foundation
  • German Society for Immunology
  • Universität Duisburg-Essen
  • China Scholarship Council
  • Mercator Research Center Ruhr

Zitieren

APA

Kirkgöz, K., Vogtmann, R., Xie, Y., Zhao, F., Riedel, A., Adam, L. M., Freitag, N., Harms, C., Garcia, M. G., Plösch, T., Gellhaus, A., & Blois, S. M. (2024). Placental glycosylation senses the anti-angiogenic milieu induced by human sFLT1 during pregnancy. Journal of Reproductive Immunology, 164, 104284. https://doi.org/10.1016/j.jri.2024.104284

Vancouver

Kirkgöz K, Vogtmann R, Xie Y, Zhao F, Riedel A, Adam LM, et al. Placental glycosylation senses the anti-angiogenic milieu induced by human sFLT1 during pregnancy. Journal of Reproductive Immunology. 2024;164:104284. doi:10.1016/j.jri.2024.104284

BibTeX
@article{Kirkgz2024,
  author = {Kirkgöz, Kürsat and Vogtmann, Rebekka and Xie, Yiran and Zhao, Fangqi and Riedel, Alina and Adam, Lisa-Marie and Freitag, Nancy and Harms, Charlotte and Garcia, Mariana G and Plösch, Torsten and Gellhaus, Alexandra and Blois, Sandra M},
  title = {Placental glycosylation senses the anti-angiogenic milieu induced by human sFLT1 during pregnancy},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  volume = {164},
  pages = {104284},
  doi = {10.1016/j.jri.2024.104284}
}
Kostenlos starten →